ReShape Lifesciences Inc (RSLS): Analyst Median Target

The price action of ReShape Lifesciences (RSLS) securities reflects the dynamics of an asset with a consensus forecast of 5821.87. The business relies on partnerships with bariatric centers, implementing advanced tools through educational courses for physicians. ReShape Lifesciences promotes the Lap-Band, a reversible weight loss method that does not affect stomach tissue, and automates production using AI-driven component geometry control.

ReShape Lifesciences Inc - RSLS Price Target Chart (period 07/04/2022 - 08/30/2025)

Analytical breakdowns for ReShape Lifesciences (RSLS)

- share price and consensus valuation forecast:

Price Performance Chart reshapelifesciences.com|RSLS - Price Target Chart

- stock exchange capitalization data:

Market Capitalization ReShape Lifesciences Inc|RSLS - Total Company Value

- company book value details:

Net Assets per Single Share ReShape Lifesciences|RSLS - Company Book Value|Market Capitalization to Book Value reshapelifesciences.com|RSLS - Cumulative Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Capital ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital reshapelifesciences.com|RSLS - Company Aggregate Debts|Debts to Book Value ReShape Lifesciences Inc|RSLS - Company Long-Term Debt|Company Short-Term Loans and Borrowings ReShape Lifesciences|Quick Ratio reshapelifesciences.com

- financial results and valuation multiples details:

RSLS - Company Net Income|Forward Earnings ReShape Lifesciences|RSLS - P/E Multiple|Projected Price to Earnings Ratio reshapelifesciences.com|RSLS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple ReShape Lifesciences Inc|RSLS - Operating profit before deduction of amortization|Earnings per share for the last four quarters ReShape Lifesciences|RSLS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months reshapelifesciences.com|RSLS - Earnings growth in current year|Expected earnings per share growth for next year ReShape Lifesciences

General company analysis:RSLS - ReShape Lifesciences, Inc.

ReShape Lifesciences' specialization in high-tech obesity management systems makes the company dependent on the market's valuation of its innovative potential. By analyzing changes in the aggregate price target for the stock, an investor can see the weighted average fair value calculated based on leading experts' forecasts for future cash flows. This indicator filters out random volatility, allowing for an assessment of the fundamental business revaluation within the context of scaling its medical devices.

Competitors of ReShape Lifesciences